Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Grimley

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Pediatric Transplantation|March 6, 2022
A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumabStefanie W Benoit, Pooja Khandelwal, Michael S Grimley
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2016
Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation PatientsAshley Teusink-Cross, Stella M Davies, Lara Danziger-Isakov, et al.
Journal of Pediatric Hematology/Oncology|August 5, 2014
Successful Treatment of Disseminated Adenovirus Infection in an Infant With Acute Lymphoblastic LeukemiaAlicia M Alcamo, Dawn E Pinchasik, Jun Qin Mo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 1, 2023
Viral specific T cell therapy in kidney transplant recipients - A single-center experienceManish Anand, Jake Nysather, Gregory McGraw, et al.
Transplantation and Cellular Therapy|February 4, 2024
Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young AdultsKristie N Ramos, Daniel Leino, Nathan Luebbering, et al.
Pediatric Transplantation|February 6, 2021
Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC)YunZu M Wang, Jonathan C Howell, Michael S Grimley, et al.
Transplantation|May 30, 2020
Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and ThiotepaPooja Khandelwal, Rosa F Yeh, Louie Yu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 1, 2014
Bortezomib for refractory autoimmunity in pediatricsPooja Khandelwal, Stella M Davies, Michael S Grimley, et al.
Blood Advances|February 25, 2020
High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapyLynn H Lee, Christa Krupski, Jason Clark, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
Post-Transplant CD34<sup>+</sup> Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune DeficienciesSharat Chandra, Jack J Bleesing, Michael B Jordan, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pediatric Transplantation|March 6, 2022
A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumabStefanie W Benoit, Pooja Khandelwal, Michael S Grimley
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2016
Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation PatientsAshley Teusink-Cross, Stella M Davies, Lara Danziger-Isakov, et al.
Journal of Pediatric Hematology/Oncology|August 5, 2014
Successful Treatment of Disseminated Adenovirus Infection in an Infant With Acute Lymphoblastic LeukemiaAlicia M Alcamo, Dawn E Pinchasik, Jun Qin Mo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 1, 2023
Viral specific T cell therapy in kidney transplant recipients - A single-center experienceManish Anand, Jake Nysather, Gregory McGraw, et al.
Transplantation and Cellular Therapy|February 4, 2024
Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young AdultsKristie N Ramos, Daniel Leino, Nathan Luebbering, et al.
Pediatric Transplantation|February 6, 2021
Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC)YunZu M Wang, Jonathan C Howell, Michael S Grimley, et al.
Transplantation|May 30, 2020
Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and ThiotepaPooja Khandelwal, Rosa F Yeh, Louie Yu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 1, 2014
Bortezomib for refractory autoimmunity in pediatricsPooja Khandelwal, Stella M Davies, Michael S Grimley, et al.
Blood Advances|February 25, 2020
High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapyLynn H Lee, Christa Krupski, Jason Clark, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2018
Post-Transplant CD34<sup>+</sup> Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune DeficienciesSharat Chandra, Jack J Bleesing, Michael B Jordan, et al.
Pageof 4